Tramadol Hydrochloride Tablet
Product Images NDC 64980-614

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 64980-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 01)

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 01)
Chemical structure diagram of Tramadol Hydrochloride, depicting the molecular arrangement including aromatic rings, functional groups, and the hydrochloride moiety.*
FDA Label Image

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 02)

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 02)
A pharmacokinetic concentration-time graph showing plasma levels (ng/mL) of Tramadol and its metabolite M1 after single and multiple doses over 48 hours. The chart compares the concentration profiles of Tramadol and M1 following both dosing regimens, with concentrations declining over time.*
FDA Label Image

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 03)

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 03)
A graph titled "Protocol CAPSS-047" showing time to discontinuation due to nausea/vomiting over days in a double-blind study. The graph compares two groups, "10 Days to 200 mg/day" and "16 Days to 200 mg/day," plotted as percent discontinuing on the vertical axis and days on the horizontal axis, with the group "10 Days to 200 mg/day" showing a higher discontinuation rate over time.*
FDA Label Image

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 04)

Image (40daac45 B987 41dd 8f3e 274acdc54e6b 04)
Label for traMADol Hydrochloride Tablets, USP 50 mg by Rising Pharmaceuticals. The label indicates 100 tablets per container, Rx only. It includes the NDC 64980-614-01 and storage instructions, notes the manufacturer as Graviti Pharmaceuticals Pvt. Ltd., India, and distributor as Rising Pharma Holdings, Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.